Ken Research Logo

Global infection control market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

The Global Infection Control Market, valued at USD 52 Bn, is growing due to increasing healthcare-associated infections and advancements in disinfection technologies.

Region:Global

Author(s):Geetanshi

Product Code:KRAC2340

Pages:90

Published On:October 2025

About the Report

Base Year 2024

Global Infection Control Market Overview

  • The Global Infection Control Market is valued at USD 52 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of healthcare-associated infections (HAIs), rising awareness regarding hygiene and sanitation, and the growing demand for sterilization and disinfection products across various sectors, including healthcare, food safety, and pharmaceuticals.
  • Key players in this market include the United States, Germany, and China, which dominate due to their advanced healthcare infrastructure, significant investments in research and development, and stringent regulations regarding infection control practices. The presence of major manufacturers and a high level of awareness among healthcare professionals further contribute to their market leadership.
  • While there is no specific regulation titled "Infection Control in Healthcare Settings" implemented by the U.S. government in 2023, healthcare facilities are required to adhere to strict infection prevention protocols. This regulation requires regular training for staff, the use of certified sterilization equipment, and the implementation of comprehensive waste disposal systems to minimize the risk of HAIs.
Global Infection Control Market Size

Global Infection Control Market Segmentation

By Type:The market is segmented into Equipment, Services, Consumables, and Others. Among these, Consumables, which include disinfectants, sterilization consumables, and personal protective equipment, are often reported as a leading sub-segment due to their continuous demand across various sectors. The growing focus on maintaining hygiene standards and preventing infections has led to a surge in the adoption of these technologies, making them essential in hospitals and clinics.

Global Infection Control Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others. Hospitals are the dominant end-user segment, driven by the increasing number of surgical procedures and the rising incidence of HAIs. The need for stringent infection control measures in hospitals has led to a higher demand for infection control products and services.

Global Infection Control Market segmentation by End-User.

Global Infection Control Market Competitive Landscape

The Global Infection Control Market is characterized by a dynamic mix of regional and international players. Leading participants such as 3M Company, Ecolab Inc., Johnson & Johnson, Steris Corporation, Becton, Dickinson and Company, Getinge AB, STERIS plc, Medline Industries, Inc., Reckitt Benckiser Group plc, Cardinal Health, Inc., Halyard Health, Inc., PDI, Inc., Ansell Limited, Kimberly-Clark Corporation, Clorox Company contribute to innovation, geographic expansion, and service delivery in this space.

3M Company

1902

St. Paul, Minnesota, USA

Ecolab Inc.

1923

St. Paul, Minnesota, USA

Johnson & Johnson

1886

New Brunswick, New Jersey, USA

Steris Corporation

1985

Dublin, Ohio, USA

Becton, Dickinson and Company

1897

Franklin Lakes, New Jersey, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

Global Infection Control Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Healthcare-Associated Infections:The World Health Organization reported that approximately 1 in 10 patients in developed countries experiences a healthcare-associated infection (HAI), translating to around 4.5 million cases annually. This alarming statistic drives the demand for effective infection control measures. The rising incidence of HAIs, particularly in surgical and intensive care units, necessitates enhanced infection control protocols, thereby propelling market growth in the future as healthcare facilities strive to improve patient safety and outcomes.
  • Rising Awareness About Infection Control Practices:A significant increase in public and professional awareness regarding infection control has been observed, particularly post-COVID-19. According to the Centers for Disease Control and Prevention, 70% of healthcare professionals now prioritize infection prevention strategies. This heightened awareness is leading to increased investments in training and resources for infection control, which is expected to boost the market in the future as healthcare providers adopt more rigorous infection control practices to safeguard patients and staff.
  • Technological Advancements in Infection Control Products:The global market for infection control technologies is projected to reach $25 billion in the future, driven by innovations such as automated disinfection systems and advanced sterilization equipment. In the future, the adoption of these technologies is accelerating, with hospitals investing in state-of-the-art solutions to enhance their infection control capabilities. This trend is supported by a growing emphasis on efficiency and effectiveness in healthcare delivery, further stimulating market growth.

Market Challenges

  • High Costs Associated with Infection Control Measures:Implementing comprehensive infection control measures can be financially burdensome for healthcare facilities. The average cost of infection prevention programs can exceed $100,000 annually for mid-sized hospitals. In the future, budget constraints often limit the ability of healthcare providers to invest in necessary technologies and training, posing a significant challenge to the effective implementation of infection control practices and potentially compromising patient safety.
  • Lack of Trained Personnel in Infection Control:A critical shortage of trained infection control professionals is evident, with estimates indicating that only 50% of healthcare facilities in the future have dedicated infection prevention staff. This lack of expertise hampers the effective implementation of infection control protocols, leading to increased risks of HAIs. The need for specialized training programs and resources is essential to address this challenge and improve overall infection control practices in the region.

Global Infection Control Market Future Outlook

The future of the infection control market in the future is poised for significant transformation, driven by technological advancements and a growing emphasis on preventive healthcare. As healthcare facilities increasingly adopt integrated solutions that leverage data analytics and IoT, the efficiency of infection control measures will improve. Additionally, the rising focus on sustainability will encourage the development of eco-friendly products, aligning with global health initiatives and regulatory standards, ultimately enhancing patient safety and operational effectiveness in healthcare settings.

Market Opportunities

  • Expansion of Healthcare Facilities in Emerging Markets:The establishment of new healthcare facilities in the future is projected to increase by 15% in the future, creating a substantial demand for infection control products and services. This expansion presents a lucrative opportunity for companies to introduce innovative solutions tailored to the needs of these new facilities, enhancing their infection prevention capabilities from the outset.
  • Growth in Demand for Advanced Sterilization Technologies:The market for advanced sterilization technologies is expected to grow significantly, with a projected increase of 20% in adoption rates in the future. This trend is driven by the need for more effective sterilization methods in healthcare settings, providing an opportunity for manufacturers to develop and market cutting-edge sterilization solutions that meet evolving regulatory standards and improve patient safety.

Scope of the Report

SegmentSub-Segments
By Type

Equipment (Sterilization Equipment, Disinfectors)

Services (Contract Sterilization, Infectious Waste Disposal)

Consumables (Disinfectants, Sterilization Consumables, Personal Protective Equipment)

Others

By End-User

Hospitals

Medical Device Companies

Clinical Laboratories

Pharmaceutical Companies

Others

By Distribution Channel

Direct Sales

Online Retail

Distributors

Wholesalers

Others

By Application

Surgical Instruments

Infection Prevention in Healthcare Settings

Environmental Disinfection

Food Safety

Others

By Product Form

Liquid

Gel

Foam

Spray

Others

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., World Health Organization, Centers for Disease Control and Prevention)

Manufacturers and Producers of Infection Control Products

Distributors and Retailers of Medical Supplies

Healthcare Providers and Hospitals

Pharmaceutical Companies

Industry Associations and Organizations

Health Insurance Companies

Players Mentioned in the Report:

3M Company

Ecolab Inc.

Johnson & Johnson

Steris Corporation

Becton, Dickinson and Company

Getinge AB

STERIS plc

Medline Industries, Inc.

Reckitt Benckiser Group plc

Cardinal Health, Inc.

Halyard Health, Inc.

PDI, Inc.

Ansell Limited

Kimberly-Clark Corporation

Clorox Company

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Global Infection Control Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Global Infection Control Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Global Infection Control Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of healthcare-associated infections
3.1.2 Rising awareness about infection control practices
3.1.3 Technological advancements in infection control products
3.1.4 Stringent government regulations on healthcare standards

3.2 Market Challenges

3.2.1 High costs associated with infection control measures
3.2.2 Lack of trained personnel in infection control
3.2.3 Resistance to change in established practices
3.2.4 Variability in regulatory compliance across regions

3.3 Market Opportunities

3.3.1 Expansion of healthcare facilities in emerging markets
3.3.2 Growth in the demand for advanced sterilization technologies
3.3.3 Increasing focus on preventive healthcare
3.3.4 Development of eco-friendly infection control products

3.4 Market Trends

3.4.1 Integration of IoT in infection control solutions
3.4.2 Shift towards personalized infection control strategies
3.4.3 Rise in telehealth and remote monitoring solutions
3.4.4 Growing emphasis on sustainability in product development

3.5 Government Regulation

3.5.1 Implementation of strict hygiene standards in healthcare
3.5.2 Mandatory reporting of healthcare-associated infections
3.5.3 Guidelines for the use of personal protective equipment (PPE)
3.5.4 Regulations on the disposal of medical waste

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Global Infection Control Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Global Infection Control Market Segmentation

8.1 By Type

8.1.1 Equipment (Sterilization Equipment, Disinfectors)
8.1.2 Services (Contract Sterilization, Infectious Waste Disposal)
8.1.3 Consumables (Disinfectants, Sterilization Consumables, Personal Protective Equipment)
8.1.4 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Medical Device Companies
8.2.3 Clinical Laboratories
8.2.4 Pharmaceutical Companies
8.2.5 Others

8.3 By Distribution Channel

8.3.1 Direct Sales
8.3.2 Online Retail
8.3.3 Distributors
8.3.4 Wholesalers
8.3.5 Others

8.4 By Application

8.4.1 Surgical Instruments
8.4.2 Infection Prevention in Healthcare Settings
8.4.3 Environmental Disinfection
8.4.4 Food Safety
8.4.5 Others

8.5 By Product Form

8.5.1 Liquid
8.5.2 Gel
8.5.3 Foam
8.5.4 Spray
8.5.5 Others

8.6 By Region

8.6.1 North America
8.6.2 Europe
8.6.3 Asia-Pacific
8.6.4 Latin America
8.6.5 Middle East & Africa
8.6.6 Others

9. Global Infection Control Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Innovation Rate
9.2.8 Distribution Efficiency
9.2.9 Brand Recognition
9.2.10 Customer Satisfaction Score

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 3M Company
9.5.2 Ecolab Inc.
9.5.3 Johnson & Johnson
9.5.4 Steris Corporation
9.5.5 Becton, Dickinson and Company
9.5.6 Getinge AB
9.5.7 STERIS plc
9.5.8 Medline Industries, Inc.
9.5.9 Reckitt Benckiser Group plc
9.5.10 Cardinal Health, Inc.
9.5.11 Halyard Health, Inc.
9.5.12 PDI, Inc.
9.5.13 Ansell Limited
9.5.14 Kimberly-Clark Corporation
9.5.15 Clorox Company

10. Global Infection Control Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers
10.1.4 Compliance Requirements

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends in Healthcare Infrastructure
10.2.2 Spending on Infection Control Technologies
10.2.3 Budgeting for Training and Compliance

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges in Implementation
10.3.2 Cost Constraints
10.3.3 Need for Training and Education

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training Needs
10.4.3 Technology Acceptance

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Effectiveness
10.5.2 Expansion Opportunities
10.5.3 Long-term Cost Savings

11. Global Infection Control Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of global infection control market reports from industry associations and health organizations
  • Review of published articles and white papers on infection control technologies and practices
  • Examination of regulatory frameworks and guidelines from WHO and CDC regarding infection control measures

Primary Research

  • Interviews with healthcare professionals, including infection control specialists and hospital administrators
  • Surveys conducted with manufacturers of infection control products and technologies
  • Field visits to healthcare facilities to observe infection control practices and product usage

Validation & Triangulation

  • Cross-validation of data through multiple sources, including market reports and expert opinions
  • Triangulation of findings from primary interviews and secondary data to ensure consistency
  • Sanity checks through expert panel discussions to validate market trends and forecasts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on global healthcare expenditure and infection rates
  • Segmentation of the market by product type, end-user, and geographical region
  • Incorporation of trends in healthcare spending and infection control initiatives by governments

Bottom-up Modeling

  • Collection of sales data from leading infection control product manufacturers
  • Estimation of market size based on unit sales and average selling prices of key products
  • Analysis of distribution channels and their impact on market penetration and growth

Forecasting & Scenario Analysis

  • Utilization of time-series analysis to project future market growth based on historical data
  • Scenario modeling based on potential changes in healthcare policies and infection outbreaks
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Infection Control Practices120Infection Control Officers, Hospital Administrators
Manufacturers of Infection Control Products80Product Managers, Sales Directors
Healthcare Facility Infection Control Compliance60Compliance Officers, Quality Assurance Managers
Public Health Initiatives on Infection Control50Public Health Officials, Policy Makers
Research on Emerging Infection Control Technologies60R&D Managers, Technology Analysts

Frequently Asked Questions

What is the current value of the Global Infection Control Market?

The Global Infection Control Market is valued at approximately USD 52 billion, driven by the increasing prevalence of healthcare-associated infections (HAIs) and the rising demand for sterilization and disinfection products across various sectors, including healthcare and food safety.

What factors are driving the growth of the Global Infection Control Market?

Which regions are leading in the Global Infection Control Market?

What are the main segments of the Global Infection Control Market?

Other Regional/Country Reports

Indonesia Infection Control Market

Malaysia Infection Control Market

KSA Infection Control Market

APAC Infection Control Market

SEA Infection Control Market

Vietnam Infection Control Market

Other Adjacent Reports

UAE Personal Protective Equipment MarketKuwait sterilization equipment market size, share, growth drivers, trends, opportunities & forecast 2025–2030

South Korea Disinfection Services Market

Japan Healthcare Waste Management Market

Belgium Antimicrobial Coatings Market

Indonesia Infection Surveillance Software Market

Oman cleanroom technology market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

Egypt Medical Device Sterilization Market

KSA Pharmaceutical Cleanliness Market

UAE Hospital Hygiene Products Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022